Tag: Cadila Healthcare

Zydus Lifesciences gets FDA final approval for BP drug generic version

businessnewstoday- November 9, 2022

Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg ... Read More

Zydus Lifesciences gets FDA final approval for Ofirmev generic

businessnewstoday- October 30, 2022

Zydus Lifesciences Limited (formerly Cadila Healthcare) said that it has secured final approval from the US Food and Drug Administration (FDA) for Acetaminophen Injection, 1,000 ... Read More

Zydus Lifesciences gets FDA final approval for Micafungin for Injection

businessnewstoday- October 26, 2022

Zydus Lifesciences (formerly Cadila Healthcare) has secured final approval for Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials from the US Food and ... Read More

Zydus Lifesciences gets FDA final approval for Toradol generic

businessnewstoday- October 23, 2022

Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has secured final approval for its analgesic drug Ketorolac Tromethamine Tablets USP, 10 mg from the US Food ... Read More

Zydus Lifesciences gets FDA tentative approval for Valbenazine Capsules

businessnewstoday- October 17, 2022

Zydus Lifesciences (previously called Cadila Healthcare) said that its subsidiary Zydus Worldwide DMCC has been given tentative approval from the US Food and Drug Administration ... Read More

Zydus Lifesciences gets FDA final approval for Brivaracetam generic

businessnewstoday- October 6, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 ... Read More

Zydus Lifesciences gets final FDA approval for Mirabegron generic

businessnewstoday- October 4, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More

Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug

businessnewstoday- October 2, 2022

Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the ... Read More

Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

- September 20, 2022

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

- September 18, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More